Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/4/2025 | $20.50 → $15.00 | Neutral → Sell | UBS |
| 11/11/2024 | $27.00 → $26.00 | Buy | TD Cowen |
| 10/17/2024 | $22.00 → $27.00 | Buy | TD Cowen |
| 8/12/2024 | $20.00 → $18.00 | Buy | TD Cowen |
| 8/18/2022 | $14.00 → $23.00 | Neutral → Buy | Goldman |
| 2/28/2022 | $23.00 → $20.00 | Outperform | Cowen |
| 2/28/2022 | $19.00 → $28.00 | Buy | HC Wainwright & Co. |
| 1/6/2022 | $23.00 | Neutral | Credit Suisse |
4 - Calumet Specialty Products Partners, L.P. (0001340122) (Issuer)
INDIANAPOLIS, Feb. 19, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) ("Calumet") announced today plans to attend the Raymond James Institutional Investors Conference on Tuesday, March 4, 2025, in Orlando, Florida. Calumet will be holding one-on-one investor meetings throughout the day at the conference. About Calumet Calumet, Inc. (NASDAQ:CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. Calumet is headquartered in Indianapolis, Indiana and operates twelve facilities throughout North America. View original content:https://www.prnewswire.com/
Initial loan proceeds of $782 million funded todayBalance of proceeds to be funded during planned expansion from 2025 through 2028DOE loan guarantee facilitates expansion of Sustainable Aviation Fuel capacity to 300 million gallons per yearINDIANAPOLIS, Feb. 18, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) ("Calumet," "we," "our" or "us") announced today that Montana Renewables, LLC, an unrestricted subsidiary of Calumet ("Montana Renewables" or "MRL"), has received its first drawdown of approximately $782 million from its $1.44 billion guaranteed loan facility with the U.S. Department of Energy ("DOE") Loan Programs Office ("LPO"). The loan funds the construction and expansion of the re
INDIANAPOLIS, Feb. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the Fourth Quarter and Fiscal Year 2024 on February 28, 2025. A conference call to discuss the financial and operational results is scheduled for February 28th at 9:00 AM ET. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides; parties interested in listening to the webcast may follow the link which will be made available at http://calumetspecialty.investorroom.com/events. For those participants w
UBS downgraded Calumet Specialty Products from Neutral to Sell and set a new price target of $15.00 from $20.50 previously
TD Cowen reiterated coverage of Calumet Specialty Products with a rating of Buy and set a new price target of $26.00 from $27.00 previously
TD Cowen reiterated coverage of Calumet Specialty Products with a rating of Buy and set a new price target of $27.00 from $22.00 previously
INDIANAPOLIS, Aug. 3, 2022 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) ("Calumet", "the Partnership", "we", "us", "our") announced today the appointment of Karen Twitchell and John (Jack) Boss to the Board of Directors effective August 2, 2022. Concurrently, Calumet announced that Robert (Bob) Funk has elected to retire from the Board of Directors. "On behalf of everyone at Calumet, I'd like to thank Bob for his many years of service and significant contributions to the Partnership. We'll particularly miss his operational expertise, wisdom and commitment to the success of Calumet," said Steve Mawer, Executive Chairman. "When Bob notified us of his intent to reti
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet, Inc. /DE (0002013745) (Issuer)
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
SC 13G/A - Calumet Specialty Products Partners, L.P. (0001340122) (Subject)
INDIANAPOLIS, Feb. 14, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the Fourth Quarter and Fiscal Year 2024 on February 28, 2025. A conference call to discuss the financial and operational results is scheduled for February 28th at 9:00 AM ET. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides; parties interested in listening to the webcast may follow the link which will be made available at http://calumetspecialty.investorroom.com/events. For those participants w
INDIANAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to hold an analysts call on January 13, 2025, at 9:00 a.m. ET to discuss the closing of its $1.44 billion guaranteed loan with the U.S. Department of Energy Loan Programs Office. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides; parties interested in listening to the webcast may follow the link which will be made available at http://calumetspecialty.investorroom.com/events. For those participants wishing to dial i
Third quarter 2024 net loss of $100.6 million, or basic loss per common share of $1.18 per shareThird quarter 2024 Adjusted EBITDA of $49.8 millionMontana Renewables ("MRL") set another new SAF production volume recordSpecialties business posted highest production levels in over five yearsMontana Renewables announced conditional commitment of $1.44 billion Department of Energy ("DOE") loanSuccessfully completed conversion from a Master Limited Partnership ("MLP") to a C-CorpINDIANAPOLIS, Nov. 8, 2024 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) today reported results of Calumet, Inc. (the "Company," "Calumet," "we," "our" or "us") for the third quarter ended September 30, 2024, as follows: T
SCHEDULE 13G/A - Calumet, Inc. /DE (0002013745) (Subject)
SCHEDULE 13G/A - Calumet, Inc. /DE (0002013745) (Subject)
SCHEDULE 13G/A - Calumet, Inc. /DE (0002013745) (Subject)